Can-Fite BioPharma CANF
NYSE CANF
$1.89 0.00 (-0.02%)
As of: Oct 21, 2026 · 3:21 PM EDT

Can-Fite BioPharma (CANF) Net Equity Issued and Repurchased (2012)

Updated

Can-Fite BioPharma's Net Equity Issued and Repurchased came in at $6.71 million for FY2025, up 49.5% from $4.49 million in FY2024.

Analysis

Can-Fite BioPharma (CANF) Net Equity Issued and Repurchased (2012) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's Net Equity Issued and Repurchased data covers 9 years.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -17.6% (FY2020 to FY2025).
  • The five-year range for annual Net Equity Issued and Repurchased is $4.49 million (FY2024) to $20.46 million (FY2021).
  • Per Business Quant, earlier years put Net Equity Issued and Repurchased at $4.49 million in FY2024 (-50.9%), $9.14 million in FY2023 and $20.46 million in FY2021 (+15.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn 138.00 Mn
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn -9.00 Mn
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn -
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn -346.00 Mn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn -
10 Can-Fite BioPharma 2.51 Mn -17.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 1.14 Mn
API Access

Can-Fite BioPharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CANF&period=max&api_key=YOUR_API_KEY